Detalhe da pesquisa
1.
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Am J Hematol
; 93(3): 416-423, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29226497
2.
Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study.
Br J Haematol
; 174(1): 71-80, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27060881
3.
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Biol Blood Marrow Transplant
; 21(3): 445-53, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25460357
4.
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 20(5): 646-54, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24462982
5.
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia.
Haematologica
; 98(6): 881-7, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23445876
6.
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC.
Curr Res Transl Med
; 67(1): 8-15, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30206045
7.
Cutaneous macroglobulinosis treated with bortezomib and rituximab.
Eur J Haematol
; 87(1): 98, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21418108
8.
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
J Clin Oncol
; 34(18): 2125-32, 2016 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27114594
9.
MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
Thromb Haemost
; 110(4): 844-51, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23903204
10.
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
J Clin Oncol
; 30(36): 4533-40, 2012 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23109707
11.
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.
Leuk Res
; 33(8): 1124-6, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18990444